Related Experiment Video
Updated: Jun 20, 2026

Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
An orally administrable hydrogen-bonded organic framework (HOF)-based nanoreactor to reprogram metabolism for
Haochen Zhang1,2, Junlin Ya1,2, Jinsong Ren1,2
1Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China.
Abstract:
Aging poses significant health challenges due to functional decline and increased disease susceptibility. Modulating age-related metabolic dysregulation offers a promising therapeutic avenue. However, the efficacy of oral therapies is severely hampered by the degradation of active agents in the harsh gastrointestinal (GI) tract. Here, we report an orally administrable hydrogen-bonded organic framework (HOF)-based nanoreactor (MAO@NADH@PB@O-HOF@PEG) designed to intervene in senescence by modulating metabolic pathways. The HOF scaffold exhibits exceptional stability in ultra-acidic conditions and boiling water, providing a robust shield for its encapsulated delicate cargo against GI degradation. This protection enables prolonged in situ catalysis within the intestine, leading to reprogramming of the gut metabolism by a catalytic degradation of the aging-elevated metabolite isoamylamine (IAA) in the intestine, serum and cerebrospinal fluid (CSF). The apoptosis and inflammation driven by elevated IAA levels are mitigated through the catalytic degradation of IAA by the HOF-based anti-aging nanoreactor. Oral administration of MAO@NADH@PB@O-HOF@PEG to aged mice significantly alleviated cognitive decline, neuronal damage and neuroinflammation. This study highlights the potential of robust HOF materials in the development of advanced oral delivery systems and geroprotective therapeutics.
Insights
This study developed a stable nanoreactor for oral delivery, effectively reducing aging-related metabolites and alleviating cognitive decline in aged mice.
Area of Science:
- Biomaterials Science
- Gerontology
- Nanotechnology
Background:
- Aging leads to functional decline and increased disease risk.
- Oral drug delivery faces challenges due to gastrointestinal degradation.
- Metabolic dysregulation is a key factor in aging.
Purpose of the Study:
- To develop a robust oral delivery system for anti-aging therapeutics.
- To create a nanoreactor capable of surviving the GI tract.
- To modulate age-related metabolic pathways and mitigate aging symptoms.
Main Methods:
- Fabrication of a hydrogen-bonded organic framework (HOF)-based nanoreactor (MAO@NADH@PB@O-HOF@PEG).
- Testing the nanoreactor's stability in extreme conditions (ultra-acidic, boiling water).
- Administering the nanoreactor orally to aged mice to assess its therapeutic effects.
Main Results:
- The HOF nanoreactor demonstrated exceptional stability against GI degradation.
- In situ catalysis within the intestine led to degradation of the aging-elevated metabolite isoamylamine (IAA).
- Oral administration significantly alleviated cognitive decline, neuronal damage, and neuroinflammation in aged mice.
Conclusions:
- HOF materials offer a promising platform for stable oral drug delivery systems.
- The developed nanoreactor effectively targets age-related metabolic dysregulation.
- This approach shows potential for developing novel geroprotective therapeutics.
Related Concept Videos
Mitochondria
Replicative Cell Senescence
Regulation of Metabolism
Replicative Cell Senescence
Whole Body Regeneration
Methods of Nuclear Reprogramming

